New York City - Events at Quotient Sciences

DCAT Seminar 2024: Addressing Complex Oral Formulation Challenges Using Translational Pharmaceutics®

New York, United States | 20 March 2024
Overview

Addressing Complex Oral Formulation Challenges Using Translational Pharmaceutics®

Optimizing drug delivery can be a challenging process. This is especially true for therapies that require complex formulation solutions, such as solubility enhancement or modified release technologies. These technologies require specialized expertise to succeed and are often limited by the predictive power of characterization methods.

Join us as Dr. Vanessa Zann, Senior Drug Development Consultant, leads a data-rich, deep-dive into a series of drug product optimization case studies on solubility enhancement and modified release. Each of these real-world examples will demonstrate how Translational Pharmaceutics® was applied to assist in formulation selection and optimization in an accelerated time frame, resulting in downstream success for our customers. 

Date/TimeLocation
Wednesday, March 20, 2024
11:30 AM - 2:00 PM
Smith and Wollensky
Brandy Room
11:30 AM - Registration
12:00 PM - 1:30 PM Lunch, Seminar, Q&A
797 Third Avenue
New York, NY 1002

Space is limited! Register your interest to attend our seminar. If you have any questions or difficulty registering, reach out to events@quotientsciences.com.

 

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register
Location
Smith and Wollensky, Brandy Room
797 Third Avenue
New York, United States

Meet our expert:

We look forward to meeting you at DCAT 2024.

Dr. Vanessa Zann

Senior Drug Development Consultant

Dr. Vanessa Zann is a Senior Drug Development Consultant at Quotient Sciences. Vanessa has over two decades of industry experience...

About Vanessa

More insight from our experts:

Read More
Oncology, Translational Pharmaceutics, Dr. Paul Quigley Insight from our experts: How Translational Pharmaceutics accelerates oncology clinical trials By: Dr. Paul Quigley
Read More
Oncology, Translational Pharmaceutics, John McDermott A Smarter Strategy for Optimizing Oncology Drug Products By: John McDermott
Read More
Get in touch
Humanity can't afford to wait, so neither can we.